Boston, MANCT07001332Now EnrollingIRB Ready

High-Risk Percutaneous Coronary Intervention (High-risk PCI) Clinical Trial in Boston, MA

Access cutting-edge high-risk percutaneous coronary intervention (high-risk pci) treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Magenta Medical Ltd.

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access high-risk percutaneous coronary intervention (high-risk pci) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related high-risk percutaneous coronary intervention (high-risk pci) treatment provided free

Apply for This Boston Location

Check if you qualify for this high-risk percutaneous coronary intervention (high-risk pci) clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This High-Risk Percutaneous Coronary Intervention (High-risk PCI) Study in Boston

The ELEVATE III Pivotal Study is a prospective, multi-center, open-label, interventional, randomized, controlled study with an active control group. The study is intended to assess the safety and efficacy of the Elevate™ percutaneous Left Ventricular Assist Device System in patients referred to high-risk percutaneous coronary interventions (HR-PCI).

Sponsor: Magenta Medical Ltd.

Who Can Participate

Inclusion Criteria

Non-emergent, percutaneous coronary intervention is planned on at least one stenotic lesion of a native coronary artery or bypass graft (de novo or restenosis).
A heart team that includes an interventional cardiologist and cardiac surgeon has determined that HR- PCI is an appropriate therapeutic option.
Participant signed the informed consent.

Exclusion Criteria

Cardiogenic shock or acutely decompensated pre-existing chronic heart failure.
Prior stroke with any permanent, significant (mRS\>2) neurological deficit, or stroke or TIA within 3 months prior to enrollment.
Any condition or scheduled surgery that will require discontinuation of the antiplatelet and/or anticoagulation therapy within 90 days of the index procedure.
Evidence of left ventricular thrombus.
Aortic valve stenosis/calcification (valve area ≤ 1.5 cm2).
≥ Moderate aortic valve regurgitation (≥ 2+ on a 4-grade scale by transthoracic echocardiography).
Femoral access site incompatibility that precludes placement of either the Treatment or Control device.
Patient on dialysis.
Known or suspected coagulopathy OR abnormal coagulation parameters.
Known allergy, sensitivity or intolerance to nickel.
Infection of the proposed procedural access site; OR suspected systemic active infection, including any fever or known active COVID-19 infection.
Allergy, sensitivity or intolerance to heparin, or contrast media, including known heparin-induced thrombocytopenia (HIT).
Any non-cardiac condition with a life expectancy \< 12 months.
Subject participation in another investigational drug or device trial (with the exception of post-market registries and observational studies, subject to Sponsor review and approval).
Pregnancy or breast-feeding.
Subject has other medical, social, or psychological problems that, in the opinion of the Investigator, compromise the participant's ability to provide written informed consent and/or to comply with study procedures.
Subject belongs to a vulnerable population.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT07001332) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

High-Risk Percutaneous Coronary Intervention (High-risk PCI) Treatment Options in Boston, MA

If you're searching for high-risk percutaneous coronary intervention (high-risk pci) treatment options in Boston, MA, this clinical trial (NCT07001332) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced high-risk percutaneous coronary intervention (high-risk pci) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all high-risk percutaneous coronary intervention (high-risk pci) clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Boston, MA

See all pulmonary embolism clinical trials recruiting in Boston — not just this study.

Browse Pulmonary Embolism Trials in Boston →

Browse More Trials by Condition

Pulmonary Embolism TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA